Itonis, Inc. (ITNS)

Market Cap	609.36K +33.3%
Revenue (ttm)	n/a
Net Income	-1.39M
EPS	-0.01
Shares Out	1.52B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,662
Open	0.0003
Previous Close	0.0004
Day's Range	0.0003 - 0.0004
52-Week Range	0.0002 - 0.0006
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Itonis

Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2005
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: ITNS

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error